Molecure to conduct cancer treatment trial in Poland
Molecure S.A. says the President of the Polish Office for Registration of Medicinal Products, Medical…
November 28, 2022 - 2 minutes
Search Results for: Cancer
Localizing BRCA gene mutations to better treat ovarian cancer
Mutations of BRCA1 and BRCA2 genes, which are inherited by 1 in 400 and 1…
November 28, 2022 - 5 minutes
Lyvgen and Bristol Myers Squibb commitment to transform cancer care
Lyvgen Biopharma announced yesterday that it has started a phase 2 trial of LVGN7409 plus…
November 28, 2022 - 3 minutes
BC Platforms partners on AI-driven EU cancer data project
BC Platforms (BCP), a provider of healthcare data management and analytics, has been chosen as…
November 24, 2022 - 2 minutes
FogPharma raises $178M to target cancer
U.S biotech company FogPharma has announced a $178 million series D financing. The financing round…
November 21, 2022 - 4 minutes
Legend Biotech small cell lung cancer drug gets FDA ok for clinical development
Legend Biotech Corporation has announced that the U.S. Food and Drug Administration (FDA) has cleared…
November 21, 2022 - 2 minutes
New discovery gives hope in fight against metastatic cancer
Cancer that splits and develops in new organs around the body becomes significantly more difficult…
November 18, 2022 - 3 minutes
Astellas meets primary endpoint in gastric cancer study
Astellas Pharma Inc. has announced positive topline results from its phase 3 SPOTLIGHT clinical trial…
November 17, 2022 - 4 minutes
Immutep announces efti clinical results for non-small cell lung cancer
Immutep Limited has revealed what it says are compelling new clinical data from its TACTI-002…
November 16, 2022 - 3 minutes
Researchers create mini ‘bone marrow in a dish’ to boost anti-cancer treatments
Scientists from Oxford University and the University of Birmingham in the U.K. have made the…
November 15, 2022 - 3 minutes
First patient dosed in Nouscom colorectal cancer study
Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized immunotherapies, says the first patient…
November 15, 2022 - 3 minutes
HUTCHMED announces positive gastric cancer study results in China
HUTCHMED (China) Limited has announced initial results from FRUTIGA, a phase III study of fruquintinib…
November 14, 2022 - 3 minutes
